Particles

US10155064B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10155064-B2
Application numberUS-201815878294-A
CountryUS
Kind codeB2
Filing dateJan 23, 2018
Priority dateMar 26, 2015
Publication dateDec 18, 2018
Grant dateDec 18, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Embolic particles are described. The particles are reaction products of a prepolymer solution including at least one polyether macromer and an appropriate monomer.

First claim

Opening claim text (preview).

We claim: 1. An embolic system including: a catheter; and spherical embolic particles having an organic polymer backbone including a reaction product of a prepolymer solution including: a poly(ethylene glycol) diacrylamide macromer, a poly(ethylene glycol) diacrylate macromer, a poly(ethylene glycol) dimethacrylate macromer, a poly(ethylene glycol) dimethacrylamide macromer, or a combination thereof; and at least one monomer, wherein the spherical embolic particles have a diameter between about 50 μm and about 1,500 μm. 2. The embolic system of claim 1 , wherein the diameter is between about 400 μm and about 1,500 μm. 3. The embolic system of claim 1 , wherein the catheter is a microcatheter. 4. The embolic system of claim 1 , wherein the at least one monomer includes ionic groups. 5. The embolic system of claim 4 , wherein the monomer containing ionic groups is sodium acrylate. 6. The embolic system of claim 1 , wherein the prepolymer solution further includes a crosslinker. 7. The embolic system of claim 6 , wherein the crosslinker is biodegradable. 8. The embolic system of claim 6 , wherein the crosslinker has a structure: wherein each n is independently 1-20; wherein d, e, f, and g are each independently 1-20; or 9. The embolic system of claim 1 , wherein the spherical embolic particles further include a visualization agent having a structure: 10. A method of treatment, the method comprising: delivering spherical embolic particles having an organic polymer backbone through a catheter to a treatment site, wherein the spherical embolic particles are formed from a reaction product of a prepolymer solution including: a poly(ethylene glycol) diacrylamide macromer, a poly(ethylene glycol) diacrylate macromer, a poly(ethylene glycol) dimethacrylate macromer, a poly(ethylene glycol) dimethacrylamide macromer, or a combination thereof; and at least one monomer, wherein the spherical embolic particles have a diameter between about 50 μm and about 1,500 μm. 11. The method of claim 10 , wherein the delivering includes flushing the catheter with a non-solvent. 12. The method of claim 11 , wherein the non-solvent is a mineral oil, hexane, or water. 13. The method of claim 11 , wherein the diameter is between about 400 μm and about 1,500 μm. 14. The method of claim 11 , wherein the catheter is a microcatheter. 15. The method of claim 11 , wherein the at least one monomer includes ionic groups. 16. The method of claim 15 , wherein the monomer containing ionic groups is sodium acrylate. 17. The method of claim 11 , wherein the prepolymer solution further includes a crosslinker. 18. The method of claim 17 , wherein the crosslinker is biodegradable. 19. The method of claim 17 , wherein the crosslinker has a structure: wherein each n is independently 1-20; wherein d, e, f, and g are each independently 1-20; or 20. The method of claim 11 , wherein the spherical embolic particles further include a visualization agent having a structure:

Assignees

Inventors

Classifications

  • for embolization or occlusion, e.g. vaso-occlusive compositions or devices · CPC title

  • Use of materials characterised by their function or physical properties · CPC title

  • A61L24/06Primary

    obtained by reactions only involving carbon-to-carbon unsaturated bonds {(A61L24/043, A61L24/046 take precedence)} · CPC title

  • Monomers containing two or more (meth)acrylamide groups, e.g. N,N'-methylenebisacrylamide · CPC title

  • Homopolymers or copolymers of acrylamide or methacrylamide · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10155064B2 cover?
Embolic particles are described. The particles are reaction products of a prepolymer solution including at least one polyether macromer and an appropriate monomer.
Who is the assignee on this patent?
Microvention Inc
What technology area does this patent fall under?
Primary CPC classification A61L24/06. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 10 related publications on this page (citations in our corpus or others sharing the same primary CPC).